Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Medical clinic in Nashville, Tennessee
2220 Pierce Ave, Nashville, TN 37232
About Vanderbilt-Ingram Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
216
Vanderbilt-Ingram Cancer Center
150
Children's Oncology Group
145
Radiation Therapy Oncology Group
47
Eastern Cooperative Oncology Group
43
Alliance for Clinical Trials in Oncology
23
SWOG Cancer Research Network
23
ECOG-ACRIN Cancer Research Group
22
Vanderbilt University
22
Bristol-Myers Squibb
15
Gynecologic Oncology Group
15
Clinical Trials at Vanderbilt-Ingram Cancer Center
During the past decade, Vanderbilt-Ingram Cancer Center conducted 367 clinical trials. In the 10-year time frame, 367 clinical trials started and 289 clinical trials were completed, i.e. on
average, 78.7% percent of trials that started reached the finish line to date. In the past 5 years, 112 clinical trials started and 129 clinical trials were completed. i.e. 115.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
1993-04-01
Completed
1,929
Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer
1997-01-01
2000-01-01
Completed
6
Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
1994-02-01
Completed
200
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
1993-12-01
Completed
216
Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
1994-03-01
2013-11-01
Completed
429
Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
1995-07-01
Completed
36
Combination Chemotherapy in Treating Children With Lymphoma
1994-07-01
2007-03-01
Completed
221
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
1994-10-01
2018-05-14
Completed
2,028
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Vanderbilt-Ingram Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 216 trials, followed by "Vanderbilt-Ingram Cancer Center" with 150 trials
sponsored, "Children's Oncology Group" with 145 trials sponsored, "Radiation Therapy Oncology Group" with 47 trials sponsored and "Eastern Cooperative Oncology Group"
with 47 trials sponsored. Other sponsors include 435 different institutions and
companies that sponsored additional 190 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Vanderbilt-Ingram Cancer Center"
#1 collaborator was "National Cancer Institute (NCI)" with 531 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Eastern Cooperative Oncology Group" with 17 trials as a collaborator, "SWOG Cancer Research Network" with 17 trials as a collaborator and "Genentech, Inc." with 15 trials as a collaborator. Other collaborators include 293 different institutions and companies that were
collaborators in the rest 160 trials.
Clinical Trials Conditions at Vanderbilt-Ingram Cancer Center
According to Clinical.Site data, the most researched conditions in "Vanderbilt-Ingram Cancer Center" are
"Head and Neck Cancer" (60 trials), "Lung Cancer" (57 trials), "Breast Cancer" (56 trials), "Leukemia" (48 trials) and "Lymphoma" (46 trials). Many other conditions were trialed in "Vanderbilt-Ingram Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Vanderbilt-Ingram Cancer Center
Most popular intervention types in "Vanderbilt-Ingram Cancer Center" are "Drug" (771 trials), "Other" (391 trials), "Procedure" (278 trials), "Biological" (267 trials) and "Radiation" (204 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (166 trials), "radiation therapy" (74 trials), "Quality-of-Life Assessment" (67 trials), "laboratory biomarker analysis" (64 trials) and "Biospecimen Collection" (59 trials). Other intervention names were less common.
Clinical Trials Genders at Vanderbilt-Ingram Cancer Center
The vast majority of trials in "Vanderbilt-Ingram Cancer Center" are
927 trials for "All" genders, 85 trials for "Female" genders and 28 trials for "Male" genders.
Clinical Trials Status at Vanderbilt-Ingram Cancer Center
Currently, there are 378 active trials in "Vanderbilt-Ingram Cancer Center".
1 are not yet recruiting,
162 are recruiting,
214 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 515 completed trials in Vanderbilt-Ingram Cancer Center,
7 suspended trials,
and 121 terminated clinical trials to date.
Out of the total trials that were conducted in Vanderbilt-Ingram Cancer Center, 191 "Phase 1"
clinical trials were conducted, 492 "Phase 2" clinical
trials and 274 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 62 trials that are defined as “Not Applicable".